GREGORY B BROWN Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for GREGORY B BROWN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of GREGORY B BROWN. GREGORY B BROWN is a Director in CAMBREX CORP ($CBM) and a Director in Caladrius Biosciences, Inc. ($NBS) and a Director in OSCIENT PHARMACEUTICALS CORP ($GENE) and a in Aquestive Therapeutics, Inc. ($AQST).
Address: 1000 WINTER STREET SUITE 2200 WALTHAM 02451 MA
Companies in which GREGORY B BROWN is an Insider
Aquestive Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of GREGORY B BROWN:
Holdings: 0 shares
Latest Transaction: Jun 18 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
CALADRIUS BIOSCIENCES, INC.
Industry: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090]
Position of GREGORY B BROWN: Director
Holdings: 83,610 shares
Latest Transaction: Jan 12 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
CAMBREX CORP
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of GREGORY B BROWN: Director
Holdings: 4,269 shares
Current Value: $233,941
Latest Transaction: Dec 05 2019
$CBM Market Capitalization: $1.70B
$CBM Previous Close: $54.80
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
OSCIENT PHARMACEUTICALS CORP
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of GREGORY B BROWN: Director
Holdings: 1,200 shares
Current Value: $1,356
Latest Transaction: Jun 13 2008
$GENE Market Capitalization: $13.04M
$GENE Previous Close: $1.13
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of GREGORY B BROWN
Sentiment: All, AQST, NBS, CBM, GENE
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 12 2021 | NBS | CALADRIUS BIOSCIEN ... | BROWN GREGORY B | Director | Grant | A | 0.00 | 37,735 | 0 | 83,610 | 45.9 K to 83.6 K (+82.26 %) |
| Jun 18 2020 | AQST | Aquestive Therapeu ... | BROWN GREGORY B | Option Exercise | A | 5.30 | 14,000 | 74,200 | 14,000 | ||
| Jan 14 2020 | NBS | CALADRIUS BIOSCIEN ... | BROWN GREGORY B | Director | Grant | A | 3.28 | 18,292 | 59,998 | 45,875 | 27.6 K to 45.9 K (+66.32 %) |
| Dec 05 2019 | CBM | CAMBREX CORP | BROWN GREGORY B | Director | Option Exercise | M | 40.06 | 2,766 | 110,806 | 0 | |
| Dec 05 2019 | CBM | CAMBREX CORP | BROWN GREGORY B | Director | Option Exercise | M | 53.70 | 1,980 | 106,326 | 0 | |
| Dec 05 2019 | CBM | CAMBREX CORP | BROWN GREGORY B | Director | Option Exercise | M | 44.23 | 360 | 15,921 | 0 | |
| Dec 05 2019 | CBM | CAMBREX CORP | BROWN GREGORY B | Director | Sell | S | 60.00 | 9,015 | 540,900 | 0 | 9 K to 0 (-100.00 %) |